Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
Clinical trial NCT05634512 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05634512
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-17
- Primary completion
- 2025-10-28
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.